Zentalis Pharmaceuticals Inc.
ZNTL | NASDAQ
$3.08
+$0.05 (+1.65%)
Sep 22, 2026, 11:40 AM ET · Market open
Company Profile
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
Key Executives
| Name | Position |
|---|---|
| Julie Eastland | Chief Executive Officer, President & Director |
| James Bucher | Chief Legal Officer & Corporate Secretary |
| Wendy Chang | Chief People Officer |
| Haibo Wang | Chief Business Officer |
| Henry Gu | Senior Vice President & Head of Intellectual Property |
| Ingmar Bruns | Chief Medical Officer |
| Rajesh Israni | Executive VP of Regulatory Affairs & Medical Writing |
| Robert J. DiVasto | Chief Technical Officer |
| Sarah Kelly | Senior Vice President of Commercial Strategy |
| Vincent Vultaggio | SVP of Finance & Principal Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 19, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 19, 2026 | 4 | Filing |
| Aug 14, 2026 | 8-K | Current Report |
| Aug 14, 2026 | 424B5 | Filing |
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | 424B5 | Filing |
| Aug 06, 2026 | 10-Q | Quarterly Report |
| Aug 06, 2026 | 8-K | Current Report |
| Jul 30, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Jun 18, 2026 | 4 | Filing |
Zentalis Pharmaceuticals Inc.
| Country | United States |
| IPO Date | Apr 2, 2020 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 106 |
| CEO | Julia Marie Eastland |
Contact Details
10275 Science Center Drive San Diego,
California 92121 United States
Stock Details
| Ticker Symbol | ZNTL |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001725160 |
| CUSIP Number | 98943L107 |
| ISIN Number | US98943L1070 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove ZNTL